Description

Levicitam 250: Comprehensive Medication Information

Ingredients:

• Each Levicitam 250 tablet contains 250 mg of Levetiracetam as the active ingredient.
• Other components include microcrystalline cellulose, colloidal anhydrous silica, croscarmellose sodium, and magnesium stearate.

Dosage:

The recommended initial dose of Levicitam 250 is 500 mg taken twice daily, with adjustments made as necessary under healthcare provider supervision.

Indications:

Levicitam 250 is prescribed for epilepsy treatment in both adults and children. It serves as an adjunctive therapy for various seizure types, including partial-onset, myoclonic, and primary generalized tonic-clonic seizures.

Contraindications:

Patients with a hypersensitivity to Levetiracetam or any tablet components should avoid Levicitam 250. Consultation with a healthcare provider is essential before starting this medication.

Directions:

Take Levicitam 250 orally as instructed by a healthcare provider, with or without food. Avoid chewing or crushing the tablets for optimal effectiveness.

Scientific Evidence:

Research, such as the study by French et al. (2001), highlights Levetiracetam’s efficacy as an add-on therapy for refractory partial seizures. It has shown a notable reduction in seizure frequency compared to a placebo. Meta-analyses, like that by Glauser et al. (2013), further support its use in epilepsy management.

Additional Information:

• Levicitam 250 is generally well-tolerated with a favorable safety profile in clinical trials.
• Common side effects may include dizziness, drowsiness, and fatigue; severe effects should be promptly reported to a healthcare provider.
• Avoid abrupt discontinuation without medical guidance.

Levicitam 250’s once-daily dosing offers convenience for individuals needing adjunctive epilepsy therapy. Its mechanism involves binding to synaptic vesicle protein 2A (SV2A), regulating neurotransmitter release and stabilizing neuronal excitability. This unique action sets Levetiracetam apart from traditional antiepileptic drugs, making it a valuable option for epilepsy patients.